Cargando…
Suppression of long non‐coding RNA TNRC6C‐AS1 protects against thyroid carcinoma through DNA demethylation of STK4 via the Hippo signalling pathway
OBJECTIVES: Thyroid carcinoma (TC) represents a malignant neoplasm affecting the thyroid. Current treatment strategies include the removal of part of the thyroid; however, this approach is associated with a significant risk of developing hypothyroidism. In order to adequately understand the expressi...
Autores principales: | Yang, Liu‐Xue, Wu, Ji, Guo, Man‐Li, Zhang, Yong, Ma, Shao‐Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536409/ https://www.ncbi.nlm.nih.gov/pubmed/30938030 http://dx.doi.org/10.1111/cpr.12564 |
Ejemplares similares
-
Long non‐coding RNA TNRC6C‐AS1 promotes methylation of STK4 to inhibit thyroid carcinoma cell apoptosis and autophagy via Hippo signalling pathway
por: Peng, Xinzhi, et al.
Publicado: (2019) -
Long Non-coding Antisense RNA TNRC6C-AS1 Is Activated in Papillary Thyroid Cancer and Promotes Cancer Progression by Suppressing TNRC6C Expression
por: Muhanhali, Dilidaer, et al.
Publicado: (2018) -
STK25 suppresses Hippo signaling by regulating SAV1-STRIPAK antagonism
por: Bae, Sung Jun, et al.
Publicado: (2020) -
Molecular basis for GIGYF–TNRC6 complex assembly
por: Sobti, Meghna, et al.
Publicado: (2023) -
TNRC6C Functions as a Tumor Suppressor and Is Frequently Downregulated in Papillary Thyroid Cancer
por: Cai, Zhenqin, et al.
Publicado: (2021)